Smart SAA- Sex smart in a click
BAUS ePoster online library. Kirby M. 06/24/19; 259531; P4-2 Disclosure(s)(s): MK has received funding for research, conference attendance, lecturing and advice from the pharmaceutical industry including Astellas, Pfizer, Takeda, Bayer, MSD, BI, Lilly, GSK, AZ and Menarini. Editor PCCJ Also on several NHS advisory boards including the Prostate cancer Risk Management Programme, The Prostate Cancer advisory Group and The National Prostate Cancer Audit.
Michael Kirby
Michael Kirby
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Rate & Comment (0)

The uptake of health reviews remains low, especially in men and for stigmatised conditions. Technology is employed to increase uptake and improve patient empowerment.

To create an App and Website which act as triage tools and allow detection of non-infectious sexual health problems and relating cardiovascular disease (CVD).

Diagnostic/management criteria for female sexual/erectile dysfunction, premature ejaculation, testosterone deficiency and LUTS were obtained from international guidelines to create an App/Website where users access validated questionnaires leading to diagnostic/management advice.


User data (N = 6721) from 03/2016 - 01/2019 suggested high levels of sexual dysfunction amenable to treatment. Regarding the erectile dysfunction (N= 2001, mean age 41y, SD = 16y) and the premature ejaculation questionnaires (N= 974, mean age 34y, SD = 14y), 83% of participants portrayed some dysfunction. Regarding testosterone levels, 83 % of participants (N= 1650, mean age 36y, SD = 14y) produced an ADAM score that warranted specialist input. 66% of females (N= 2060, mean age 33y, SD = 15y) reported sexual dysfunction. 75% of females and 94% of males reported LUTS.


This is the first App/Website supporting health screening for the above urological conditions. Benefits include easy access, cost free, a triage tool function, provision of a preliminary diagnosis and symptom support. Given that erectile dysfunction and testosterone deficiency are predictors of CVD and have been incorporated into cardiovascular risk calculators (QRisk 3), this tool may aid diagnosis of (early) CVD, providing a window of opportunity for appropriate lifestyle changes and pharmacological management.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings